PCM
CDLX icon

Penn Capital Management’s Cardlytics CDLX Stock Holding History

Penn Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,048
Closed -$4.44M – 209
2021
Q1 		$4.44M Sell
4,048
-674
-14% -$890K 0.46% 76
2020
Q4 		$6.74M Sell
4,722
-1,245
-21% -$1.33M 0.85% 54
2020
Q3 		$4.22M Buy
5,967
+250
+4% +$182K 0.53% 76
2020
Q2 		$4.01M Sell
5,717
-921
-14% -$532K 0.52% 80
2020
Q1 		$2.32M Sell
6,638
-2,477
-27% -$1.75M 0.38% 109
2019
Q4 		$5.73M Sell
9,115
-11,485
-56% -$5.62M 0.6% 59
2019
Q3 		$6.91M Buy
+20,600
New +$6.6M 0.72% 46

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return

Penn Capital Management's CDLX Position: Q2 2021 in Review

Penn Capital Management sold out of Cardlytics (CDLX) in Q2 2021, closing a stake of 4,048 shares — an estimated $4.44M sold.

Penn Capital Management first reported a position in CDLX in Q3 2019 and held it in 7 quarters. The position peaked at $6.91M in Q3 2019. 189 funds tracked by Wall St. Rank hold CDLX as of Q2 2021.

  • Penn Capital Management reported no remaining Cardlytics position as of Q2 2021 after selling out during the quarter.
  • Penn Capital Management sold 4,048 Cardlytics shares in Q2 2021, an estimated $4.44M.
  • Penn Capital Management first reported a position in Cardlytics in Q3 2019 and held it in 7 quarters.
  • Penn Capital Management's Cardlytics position peaked at $6.91M in Q3 2019.
  • 189 funds tracked by Wall St. Rank held Cardlytics as of Q2 2021.

Based on Penn Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.